|
2023
|
Invention
|
2a receptor inverse agonist, and preparation method therefor and use thereof. 2A2A2A receptor-rel... |
|
2022
|
P/S
|
Medicines for human purposes; Chemical preparations for pharmaceutical purposes; Biochemical prep... |
|
2020
|
Invention
|
Compound and preparation method therefor and use thereof.
Provided are a novel impurity compound... |
|
|
Invention
|
Vmat2 inhibitor and preparation method therefor and use thereof. The present invention relates to... |
|
|
P/S
|
Pharmaceutical preparation for the treatment of depression |
|
|
Invention
|
Rotigotine behenate, and manufacturing method and application thereof. The present disclosure rel... |
|
|
P/S
|
Medicines for human purposes; chemico-pharmaceutical
preparations; dietetic substances adapted f... |
|
2018
|
Invention
|
Dosage regimen of paliperidone palmitate extended-release injectable suspension. Provided herein ... |
|
2016
|
P/S
|
Medicines for human purposes for treatment of psychiatric and mental disorders, schizophrenia and... |
|
2014
|
Invention
|
Long acting sustained-release formulation containing dopamine receptor agonist and the preparatio... |
|
2012
|
Invention
|
5,6,7,8-tetrahydro-6-[n,n-bis[(2-thienyl)ethyl]] amino-1-naphthol, and preparing method and use t... |
|
|
Invention
|
5,6,7,8-tetrahydro-6-[n,n-bis[(2-thienyl)ethyl]]amino-1-naphthol, and preparing method and use th... |
|
|
Invention
|
Risperidone sustained release microsphere composition. A risperidone sustained release microspher... |
|
2011
|
Invention
|
Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigoti... |
